JUAN VASQUEZ: Open Payments
NPI 1093981607 · GRANDVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,200 in 136 payments from 17 companies in 2025. Trend: 2023 $2,207 · 2024 $2,559 · 2025 $2,200
Food & beverage: $2,200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $601 |
| Novartis Pharmaceuticals Corporation | 21 | $428 |
| UCB, Inc. | 9 | $178 |
| PFIZER INC. | 11 | $168 |
| GENZYME CORPORATION | 8 | $164 |
| Arcutis Biotherapeutics, Inc. | 8 | $146 |
| LEO Pharma Inc. | 5 | $87 |
| Incyte Corporation | 3 | $68 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $65 |
| Organon LLC | 6 | $56 |
Products named: COSENTYX, RINVOQ, SKYRIZI, Bimzelx, DUPIXENT, Zoryve, EUCRISA, ADBRY.
Industry payments across MI — which companies pay providers there.
